VINTAFECT
DEAD

Serial Number

98800120

Owner

Vintabio, Inc.

Attorney

Julia M. Chester

Filing Date

Oct 14, 2024

Add to watchlist:

No watchlists yet
View on USPTO

VINTAFECT Trademark

Serial Number: 98800120

VINTAFECT is a trademark filed by Vintabio, Inc. on October 14, 2024. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Vintabio, Inc. (4 trademarks)

4050 S. 26th St., Suite 200
Philadelphia, PA 19102

Entity Type: 03

Trademark Details

Filing Date

October 14, 2024

Registration Date

Not Registered

Goods & Services

Manufacturing services for others in the field of biologics; manufacturing services for others in the field of transient transfection technology; biomanufacturing for others, namely, manufacturing of gene therapy products using biological organisms in the manufacturing process; cell therapy manufacturing for others; providing technical information in the field of pharmaceutical manufacturing; biomanufacturing of viral vectors and gene therapy vectors; biomanufacturing services of cell lines and cells

Product research and development in the fields of biology and medical sciences; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of biologics; pharmaceutical drug and biologics delivery technology development services, namely, research and development in the area of pharmaceutical drug and biologics delivery systems in the nature of viral vectors; biological research and analysis; consulting services in the fields of research and development of biologics; scientific and technological services, namely, scientific research, analysis and testing in the field of biological vectors; scientific research services in the field of cell modification; pharmaceutical research services, namely, protein and cell line development and production; genetic engineering services utilizing a collection of genetic technologies for the rapid production of cell lines; scientific, laboratory and medical research in the field of cell line engineering; scientific laboratories performing cell line development; scientific research and development, namely, development of cell lines and proteins for others

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Nov 10, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 10, 2025 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 24, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 24, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 24, 2025 GNRN
NON-FINAL ACTION E-MAILED
Apr 24, 2025 GNRT
NON-FINAL ACTION WRITTEN
Apr 24, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 16, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 15, 2025 NWOS
NEW APPLICATION ENTERED
Oct 14, 2024 NWAP